← Leaderboards
Joel D. Ernst
University Of California San Francisco
$38,250,253
Attributed
$47,113,825
Total exposure
25
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$67,165,145 · 26
By mechanism
R01$36,011,149 · 10
U19$24,358,348 · 4
R21$2,574,594 · 6
U01$2,566,261 · 1
R56$819,863 · 2
T32$527,094 · 1
Top collaborators
- Adithya Cattamanchi12 shared
- Henry M Blumberg9 shared
- Sebastien Gagneux5 shared
- John Altin4 shared
- Carl Guangda Feng4 shared
- Matthew L Kutys2 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Philip C Hopewell$14,392,658
- Kevan M. Shokat$21,480,540
- Ronald H Jensen$514,597
- Paul Montellano$0
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisInfectionAntigensResponseImmune ResponseImmunityTuberculosis VaccinesT Cell ResponseBacteriaT-LymphocytePathogenCellsCd4 Positive T LymphocytesMacrophageImmuneIn VivoInsightCharacteristicsTuberculosis ImmunityVaccine DevelopmentDendritic CellsLungPhenotype
Grant awards (109)
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$1,061,038
R01 · FY2025 · AI
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens$836,129
R01 · FY2025 · AI · contact PI
Functional dynamics of TB granuloma architecture$617,682
U01 · FY2025 · AI · contact PI
A novel approach to determine the value of ESAT-6 as an antigen in M. tuberculosis infection and vaccines$278,390
R21 · FY2025 · AI · contact PI
3D biomimetic human tuberculosis granulomas to identify novel host-pathogen interactions$195,819
R21 · FY2025 · AI · contact PI
Functional dynamics of TB granuloma architecture$59,260
U01 · FY2025 · AI · contact PI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$41,814
R01 · FY2025 · AI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$1,831
R01 · FY2025 · AI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,278,151
R01 · FY2024 · AI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$1,025,117
R01 · FY2024 · AI
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens$849,367
R01 · FY2024 · AI · contact PI
Functional dynamics of TB granuloma architecture$616,269
U01 · FY2024 · AI · contact PI
Childhood Omics and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$347,159
R01 · FY2024 · AI
3D biomimetic human tuberculosis granulomas to identify novel host-pathogen interactions$242,250
R21 · FY2024 · AI
Functional dynamics of TB granuloma architecture - Diversity Supplement for Kelley J. Martinez$33,610
U01 · FY2024 · AI · contact PI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,410,811
R01 · FY2023 · AI
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study$1,105,532
R01 · FY2023 · AI
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens$855,091
R01 · FY2023 · AI · contact PI
Functional dynamics of TB granuloma architecture$615,683
U01 · FY2023 · AI · contact PI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,039,959
R01 · FY2022 · AI
Functional dynamics of TB granuloma architecture$623,757
U01 · FY2022 · AI · contact PI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$518,294
R01 · FY2022 · AI
Live Imaging of Immunity to M. tuberculosis$100,965
R21 · FY2022 · AI · contact PI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,490,544
R01 · FY2021 · AI
Live Imaging of Immunity to M. tuberculosis$289,901
R21 · FY2021 · AI · contact PI
A novel approach for deep phenotyping the CD4 T cell response to Mycobacterium Tuberculosis$280,275
R21 · FY2021 · AI
Host genetic diversity, T cell responses, and outcomes of TB$181,165
R21 · FY2021 · AI · contact PI
Host genetic diversity, mononuclear phagocytes, and outcomes of TB$161,500
R21 · FY2021 · AI · contact PI
Role of antigen-specific T cell responses in the control of TB$2,826,310
U19 · FY2020 · AI
Childhood âOmicsâ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings$1,503,586
R01 · FY2020 · AI
Human T cell responses permissive for progression to active TB disease$888,177
U19 · FY2020 · AI · contact PI
Host genetic diversity, T cell responses, and outcomes of TB$306,790
R21 · FY2020 · AI · contact PI
Host genetic diversity, mononuclear phagocytes, and outcomes of TB$282,333
R21 · FY2020 · AI · contact PI
ConProject-001$255,967
U19 · FY2020 · AI
A novel approach for deep phenotyping the CD4 T cell response to Mycobacterium Tuberculosis$255,206
R21 · FY2020 · AI
Project-004$102,023
U19 · FY2020 · AI
Role of antigen-specific T cell responses in the control of TB$2,872,556
U19 · FY2019 · AI
Antigen export in M. tuberculosis evasion of CD4 T cells$666,902
R01 · FY2019 · AI · contact PI
Human T cell responses permissive for progression to active TB disease$611,486
U19 · FY2019 · AI · contact PI
Cellular and Bacterial Dynamics in Tuberculosis$545,842
R01 · FY2019 · AI · contact PI
Role of antigen-specific T cell responses in the control of TB$2,905,098
U19 · FY2018 · AI
Antigen export in M. tuberculosis evasion of CD4 T cells$623,115
R01 · FY2018 · AI · contact PI
Cellular and Bacterial Dynamics in Tuberculosis$577,349
R01 · FY2018 · AI · contact PI
Human T cell responses permissive for progression to active TB disease$503,047
U19 · FY2018 · AI · contact PI
Antigen export in M. tuberculosis evasion of CD4 T cells$22,802
R01 · FY2018 · AI · contact PI
Role of antigen-specific T cell responses in the control of TB$2,898,702
U19 · FY2017 · AI
Antigen export in M. tuberculosis evasion of CD4 T cells$720,090
R01 · FY2017 · AI · contact PI
Cellular and Bacterial Dynamics in Tuberculosis$577,349
R01 · FY2017 · AI · contact PI
Human T cell responses permissive for progression to active TB disease$373,936
U19 · FY2017 · AI · contact PI
Role of antigen-specific T cell responses in the control of TB$2,910,650
U19 · FY2016 · AI
Antigen export in M. tuberculosis evasion of CD4 T cells$704,472
R01 · FY2016 · AI · contact PI
Cellular and Bacterial Dynamics in Tuberculosis$577,349
R01 · FY2016 · AI · contact PI
Human T cell responses permissive for progression to active TB disease$373,273
U19 · FY2016 · AI · contact PI
Role of antigen-specific T cell responses in the control of TB$2,933,100
U19 · FY2015 · AI
Human T cell responses permissive for progression to active TB disease$733,484
U19 · FY2015 · AI · contact PI
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo$393,538
R01 · FY2015 · AI · contact PI
Role of antigen-specific T cell responses in the control of TB$2,704,904
U19 · FY2014 · AI
Mycobacterium tuberculosis antigen diversity$612,156
R01 · FY2014 · AI · contact PI
Cellular and Bacterial Dynamics in Tuberculosis$600,349
R01 · FY2014 · AI · contact PI
Initiation of the Immune Response to M. tuberculosis$505,895
R01 · FY2014 · AI · contact PI
Epitope-specific T cell activation to complement TB immunity and vaccine efficacy$502,456
R56 · FY2014 · AI · contact PI
Human T cell responses permissive for progression to active TB disease$465,635
U19 · FY2014 · AI · contact PI
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo$364,232
R01 · FY2014 · AI · contact PI
Training Program in Immunology and Inflammation$199,524
T32 · FY2014 · AI · contact PI
Training Program in Immunology and Inflammation.$131,306
T32 · FY2014 · AI · contact PI
Mycobacterium tuberculosis antigen diversity$595,619
R01 · FY2013 · AI · contact PI
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo$369,926
R01 · FY2013 · AI · contact PI
Training Program in Immunology and Inflammation$196,264
T32 · FY2013 · AI · contact PI
Mycobacterium tuberculosis antigen diversity$647,571
R01 · FY2012 · AI · contact PI
Initiation of the Immune Response to M. tuberculosis$526,128
R01 · FY2012 · AI · contact PI
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo$393,538
R01 · FY2012 · AI · contact PI
Mycobacterium tuberculosis antigen diversity$674,536
R01 · FY2011 · AI · contact PI
Initiation of the Immune Response to M. tuberculosis$526,343
R01 · FY2011 · AI · contact PI
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo$405,038
R01 · FY2011 · AI · contact PI
Mycobacterium tuberculosis antigen diversity$664,613
R01 · FY2010 · AI · contact PI
Initiation of the Immune Response to M. tuberculosis$530,161
R01 · FY2010 · AI · contact PI
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo$413,507
R01 · FY2010 · AI · contact PI
Initiation of the Immune Response to M. tuberculosis$519,922
R01 · FY2009 · AI · contact PI
Mycobacterium tuberculosis evasion of CD4+ T cells in vivo$317,407
R56 · FY2009 · AI · contact PI
Initiation of the Immune Response to M. tuberculosis$534,000
R01 · FY2008 · AI · contact PI
M. tuberculosis evasion of immune effector mechanisms$501,088
R01 · FY2008 · AI · contact PI
Type I Interferons in Immunity to Tuberculosis$392,994
R01 · FY2008 · AI · contact PI
M. tuberculosis evasion of immune effector mechanisms$517,655
R01 · FY2007 · AI · contact PI
Type I Interferons in Immunity to Tuberculosis$400,606
R01 · FY2007 · AI · contact PI
M. tuberculosis evasion of immune effector mechanisms$520,436
R01 · FY2006 · AI · contact PI
Initiation of the Immune Response to M. tuberculosis$458,915
R01 · FY2006 · AI · contact PI
Type I Interferons in Immunity to Tuberculosis$412,571
R01 · FY2006 · AI · contact PI
Initiation of the Immune Response to M. tuberculosis$468,481
R01 · FY2005 · AI
M. tuberculosis evasion of immune effector mechanisms$458,497
R01 · FY2005 · AI
Type I Interferons in Immunity to Tuberculosis$422,500
R01 · FY2005 · AI
M. tuberculosis evasion of immune effector mechanisms$58,893
R01 · FY2005 · AI
M. tuberculosis evasion of immune effector mechanisms$470,842
R01 · FY2004 · AI
Initiation of the Immune Response to M. tuberculosis$467,046
R01 · FY2004 · AI
Type I Interferons in Immunity to Tuberculosis$401,110
R01 · FY2004 · AI
Initiation of the Immune Response to M. tuberculosis$461,514
R01 · FY2003 · AI
M TUBERCULOSIS EVASION OF IMMUNE EFFECTOR MECHANISMS$338,728
R01 · FY2003 · AI
Tuberculosis Immunity: Essential Host Genes$75,750
R03 · FY2003 · AI
Initiation of the Immune Response to M. tuberculosis$328,464
R01 · FY2002 · AI
M TUBERCULOSIS EVASION OF IMMUNE EFFECTOR MECHANISMS$177,022
R01 · FY2002 · AI
M TUBERCULOSIS EVASION OF IMMUNE EFFECTOR MECHANISMS$151,841
R01 · FY2002 · AI
Initiation of the Immune Response to M. tuberculosis$82,874
R01 · FY2002 · AI
Tuberculosis Immunity: Essential Host Genes$66,667
R03 · FY2002 · AI
Tuberculosis Immunity: Essential Host Genes$8,666
R03 · FY2002 · AI
DEVELOPMENT OF IMMUNE EVASION IN TUBERCULOSIS$0
P01 · FY2002 · AI
M TUBERCULOSIS EVASION OF IMMUNE EFFECTOR MECHANISMS$319,286
R01 · FY2001 · AI
DEVELOPMENT OF IMMUNE EVASION IN TUBERCULOSIS$0
P01 · FY2001 · AI
M TUBERCULOSIS EVASION OF IMMUNE EFFECTOR MECHANISMS$309,986
R01 · FY2000 · AI
MYCOBACTERIUM TUBERCULOSIS;INDUCED MACROPHAGE SIGNALLING$233,035
R01 · FY2000 · HL
DEVELOPMENT OF IMMUNE EVASION IN TUBERCULOSIS$156,753
P01 · FY2000 · AI